Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Brain Neoplasms 21Breast Neoplasms 17Neoplasms 7Fatigue 6Colorectal Neoplasms 6Colonic Neoplasms 6Central Nervous System Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 5Glioma 5Small Cell Lung Carcinoma 4Neurotoxicity Syndromes 4Neoplasm Metastasis 4Glioblastoma 4Rectal Neoplasms 3Radiation Injuries 3Lymphoma 3Hematologic Neoplasms 3Depression 3Breast Neoplasms, Male 3Unspecified Adult Solid Tumor, Protocol Specific 2Prostatic Neoplasms 2Pain 2Oligodendroglioma 2Meningioma 2Medulloblastoma 2Malnutrition 2Leukemia 2Head and Neck Neoplasms 2Gliosarcoma 2

Interventions

pembrolizumab 163Carboplatin 146Paclitaxel 125Cyclophosphamide 94130-nm albumin-bound paclitaxel 66Capecitabine 64Gemcitabine 54Doxorubicin 50Albumin-Bound Paclitaxel 45Taxes 42atezolizumab 41Cisplatin 39sacituzumab govitecan 34Nivolumab 34olaparib 32Epirubicin 32Specimen Handling 28Docetaxel 28eribulin 27Bevacizumab 26durvalumab 25Drug Therapy 25Biopsy 24camrelizumab 23Magnetic Resonance Spectroscopy 22toripalimab 19Radiotherapy 17spartalizumab 16Everolimus 15veliparib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Mental Status and Dementia Tests × Clear all
NCT06582615 2025-12-11

MIND-TNBC

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
60 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡